Heart failure drug safety checked in japanese patients
NCT ID NCT05666518
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 22 times
Summary
This study looks at the safety of a drug called vericiguat in Japanese people with chronic heart failure. Researchers will track side effects and see how long the drug can prevent heart-related deaths compared to standard care. About 1400 participants will be followed for up to 2 years. The goal is to gather real-world information on the drug's safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Japanese registries
RECRUITINGMultiple Locations, Many Locations, Japan
Conditions
Explore the condition pages connected to this study.